LEIDEN, Netherlands--(BUSINESS WIRE)--Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead ...
"At Catalyst, everything begins with patients. Our presence at these scientific meetings reflects our ongoing commitment to advancing differentiated therapies that can meaningfully impact the lives of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback